965 related articles for article (PubMed ID: 9472608)
1. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
2. Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity.
Ansari SA; Safak M; Gallia GL; Sawaya BE; Amini S; Khalili K
J Gen Virol; 1999 Oct; 80 ( Pt 10)():2629-2638. PubMed ID: 10573156
[TBL] [Abstract][Full Text] [Related]
3. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
4. Regulation of HIV-1 gene expression by NF-IL6.
Tesmer VM; Bina M
J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur alpha in glial cells.
Chen NN; Khalili K
J Virol; 1995 Sep; 69(9):5843-8. PubMed ID: 7637031
[TBL] [Abstract][Full Text] [Related]
8. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
[TBL] [Abstract][Full Text] [Related]
9. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
10. Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription.
Sawaya BE; Khalili K; Mercer WE; Denisova L; Amini S
J Biol Chem; 1998 Aug; 273(32):20052-7. PubMed ID: 9685344
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B
J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512
[TBL] [Abstract][Full Text] [Related]
12. Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene.
Imataka H; Sogawa K; Yasumoto K; Kikuchi Y; Sasano K; Kobayashi A; Hayami M; Fujii-Kuriyama Y
EMBO J; 1992 Oct; 11(10):3663-71. PubMed ID: 1356762
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1.
Raj GV; Safak M; MacDonald GH; Khalili K
J Virol; 1996 Sep; 70(9):5944-53. PubMed ID: 8709216
[TBL] [Abstract][Full Text] [Related]
15. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
16. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
Yurochko AD; Huong SM; Huang ES
J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
[TBL] [Abstract][Full Text] [Related]
18. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.
Harrich D; Garcia J; Wu F; Mitsuyasu R; Gonazalez J; Gaynor R
J Virol; 1989 Jun; 63(6):2585-91. PubMed ID: 2657100
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions.
Wang W; Dong L; Saville B; Safe S
Mol Endocrinol; 1999 Aug; 13(8):1373-87. PubMed ID: 10446910
[TBL] [Abstract][Full Text] [Related]
20. A Y-box protein is a suppressor factor that decreases thyrotropin receptor gene expression.
Ohmori M; Shimura H; Shimura Y; Kohn LD
Mol Endocrinol; 1996 Jan; 10(1):76-89. PubMed ID: 8838147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
